Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600992 | 12660099 | 2 | F | 2016 | 20160822 | 20160817 | 20160826 | EXP | US-ABBVIE-16P-163-1701641-00 | ABBVIE | 0.00 | M | Y | 96.80000 | KG | 20160826 | MD | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600992 | 12660099 | 1 | PS | VENCLEXTA | VENETOCLAX | 1 | Oral | TAKEN AS DIRECTED | Y | U | 1058413 | 208573 | 20 | MG | TABLET | ||||
| 126600992 | 12660099 | 2 | SS | VENCLEXTA | VENETOCLAX | 1 | Oral | Y | U | 1058413 | 208573 | 50 | MG | TABLET | |||||
| 126600992 | 12660099 | 3 | SS | VENCLEXTA | VENETOCLAX | 1 | Oral | Y | U | 1058413 | 208573 | TABLET | |||||||
| 126600992 | 12660099 | 4 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | Y | UNKNOWN | 0 | 300 | MG | |||||||
| 126600992 | 12660099 | 5 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Y | UNKNOWN | 0 | ||||||||||
| 126600992 | 12660099 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | 40 | MG | ||||||||||
| 126600992 | 12660099 | 7 | C | ASPIRIN. | ASPIRIN | 1 | 0 | 81 | MG | ||||||||||
| 126600992 | 12660099 | 8 | C | ACYCLOVIR. | ACYCLOVIR | 1 | 0 | 400 | MG | ||||||||||
| 126600992 | 12660099 | 9 | C | REVLIMID | LENALIDOMIDE | 1 | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126600992 | 12660099 | 1 | Plasma cell leukaemia |
| 126600992 | 12660099 | 4 | Tumour lysis syndrome |
| 126600992 | 12660099 | 5 | Prophylaxis |
| 126600992 | 12660099 | 6 | Product used for unknown indication |
| 126600992 | 12660099 | 7 | Product used for unknown indication |
| 126600992 | 12660099 | 8 | Product used for unknown indication |
| 126600992 | 12660099 | 9 | Plasma cell leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126600992 | 12660099 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126600992 | 12660099 | Acute kidney injury | |
| 126600992 | 12660099 | Dehydration | |
| 126600992 | 12660099 | Drug reaction with eosinophilia and systemic symptoms | |
| 126600992 | 12660099 | Muscular weakness | |
| 126600992 | 12660099 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126600992 | 12660099 | 1 | 20160718 | 20160725 | 0 | |
| 126600992 | 12660099 | 2 | 20160726 | 20160807 | 0 | |
| 126600992 | 12660099 | 3 | 20160822 | 0 | ||
| 126600992 | 12660099 | 4 | 2016 | 20160807 | 0 |